Cancer Genetics: Why It Matters for Primary Care Practice
This workshop provides an opportunity to learn more about how cancer genetics impact your patients across the care continuum, where to find screening tools to collect a complete family history on your patients, how to find genetic counseling and testing resources in the state, and get the latest updates on the two most common hereditary cancer syndromes (Hereditary Breast and Ovarian Cancer and Lynch syndrome).
Continuing education is approved. See Accreditation Statements below for more information.
This FREE workshop is targeted for primary care providers and other clinical staff.
CME activities with Joint Providers: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and Gastroenterology of the Rockies; Centura Health; SCL Health; Colorado Department of Public Health and Environment .The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Centers for Disease Control and Prevention designates this live activity for a maximum of (1.75) AMA PRA Category 1 Credits™.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides (1.7) contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer (0.2) CEU’s for this program.
DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, presenters, and their spouses/partners wish to disclose they have no no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Dr. Dennis J. Ahnen MD, AGAF, FACG and Ms. Shonee Lesh, MS, CGC. Dr. Ahnen wishes to disclose he serves on the Ambry Genetics Speakers Bureau. “I give an occasional talk on hereditary colon cancer syndromes sponsored by Ambry Genetics (I have given one a few years ago and gave one in May 2018).” Additionally, he is a member of the Data and Safety Monitoring Board for a clinical trial for Cancer Prevention Pharmaceuticals. Ms. Lesh wishes to disclose she works for Progeny Genetics, a family history data software company. Planning committee discussed conflict of interest with Dr. Ahnen to ensure there is no bias. Planning committee discussed conflict of interest with Ms. Lesh to ensure there is no bias. CDC did not accept commercial support for this continuing education activity.
If CNE Joint Provider: The Centers for Disease Control and Prevention and Gastroenterology of the Rockies; Centura Health; SCL Health; Colorado Department of Public Health and Environment are jointly providing the CNE for this activity.
CDC did not accept any commercial support for this continuing education activity.
Instructions for Obtaining Continuing Education (CE)
The course access code is [CancerGenetics2018].
Complete the activity
Complete the Evaluation at www.cdc.gov/GetCE
Pass the posttest at 75% at www.cdc.gov/GetCE (if applicable)
FEES: There are no fees for CE.